Zhang et al., 2022b)
Albert Goday has received fees for investigation projects, consulting, and postgraduate training, and has participated in clinical trials sponsored by Almirall, Ascensia, Colegio de Farmacuticos de Barcelona, Esteve, Federacin Farmacutica, Fundacin Catalana Sndrome de Down, Fundaci Gol i Gorina, Instituto de Salud Carlos III, Jansen, Lilly, Menarini, MSD, Mutuam, Novo Nordisk, Pronokal, RedGDPS, Rovi, Sanofi Aventis
Another 3.3 million people were interested in using weight-loss drugs in the near future, especially people who are struggling financially, among whom obesity is more prevalent, the study said
Medical providers and their assistants are having to deal with many, many emails, phone calls and visits from patients who either want to start weight loss drugs or have questions once they are using them
Here's what she shared